表紙
市場調查報告書

青光眼排液設備:醫療設備開發平台評估(2020年)

Glaucoma Drainage Devices - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 955249
出版日期 內容資訊 英文
訂單完成後即時交付
價格
青光眼排液設備:醫療設備開發平台評估(2020年) Glaucoma Drainage Devices - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年08月01日內容資訊: 英文
簡介

青光眼排液設備或植入,透過外科手術安裝到眼睛表面的小型塑膠裝置,改善淚液等的流動。

本報告提供青光眼排液設備的相關調查,產品概要,許可證,合作,開發活動,主要開發中產品詳細內容等資訊。

目錄

第1章 目錄

  • 表格的清單
  • 圖的清單

第2章 簡介

  • 青光眼排液設備概要

第3章 開發中的產品

  • 各開發階段
  • 各地區
  • 各調整通行證
  • 各估計核准日
  • 持續性臨床試驗

第4章 企業開發中的開發中產品

  • 青光眼排液設備企業
  • 青光眼排液設備

第5章 青光眼排液設備的企業及產品概要

  • Alievio Inc
  • Avisi Technologies LLC
  • Geuder AG
  • InnFocus Inc
  • iVeena Delivery Systems Inc
  • Medtronic Plc
  • Meir Medical Center
  • Merz Anteis SA
  • MicroOptx, Inc.
  • OPKO Health Inc
  • Purdue University
  • Sheba Medical Center
  • Tel Aviv University
  • University of Colorado
  • University of Michigan

第6章 最近的開發

  • 2020年5月13日:OPKO Health的BioReference Laboratories和Westchester Medical Center Health Network的實驗室的合作開始
  • 2019年11月5日:OPKO Health的2019年第3季商務亮點和決算的發表
  • 2019年8月30日:參天製藥的DE-128(MicroShunt)的主要資料的發表

第7章 附錄

  • 調查手法
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
目錄
Product Code: GDME0976EPD

GlobalData's Medical Devices sector report, "Glaucoma Drainage Devices- Medical Devices Pipeline Assessment, 2020 " provides comprehensive information about the Glaucoma Drainage Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Glaucoma drainage device or implant is a small plastic device that is surgically attached to the eye's surface to improve or shunt the flow of aqueous drainage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Glaucoma Drainage Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Glaucoma Drainage Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Glaucoma Drainage Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Glaucoma Drainage Devices Overview

3 Products under Development

  • 3.1 Glaucoma Drainage Devices - Pipeline Products by Stage of Development
  • 3.2 Glaucoma Drainage Devices - Pipeline Products by Territory
  • 3.3 Glaucoma Drainage Devices - Pipeline Products by Regulatory Path
  • 3.4 Glaucoma Drainage Devices - Pipeline Products by Estimated Approval Date
  • 3.5 Glaucoma Drainage Devices - Ongoing Clinical Trials

4 Glaucoma Drainage Devices - Pipeline Products under Development by Companies

  • 4.1 Glaucoma Drainage Devices Companies - Pipeline Products by Stage of Development
  • 4.2 Glaucoma Drainage Devices - Pipeline Products by Stage of Development

5 Glaucoma Drainage Devices Companies and Product Overview

  • 5.1 Alievio Inc Company Overview
  • 5.2 Avisi Technologies LLC Company Overview
  • 5.3 Geuder AG Company Overview
  • 5.4 InnFocus Inc Company Overview
  • 5.5 iVeena Delivery Systems Inc Company Overview
  • 5.6 Medtronic Plc Company Overview
  • 5.7 Meir Medical Center Company Overview
  • 5.8 Merz Anteis SA Company Overview
  • 5.9 MicroOptx, Inc. Company Overview
  • 5.10 OPKO Health Inc Company Overview
  • 5.11 Purdue University Company Overview
  • 5.12 Sheba Medical Center Company Overview
  • 5.13 Tel Aviv University Company Overview
  • 5.14 University of Colorado Company Overview
  • 5.15 University of Michigan Company Overview

6 Glaucoma Drainage Devices- Recent Developments

  • 6.1 May 13, 2020: OPKO Health's BioReference Laboratories and Westchester Medical Center Health Network enter into strategic laboratory collaboration to deliver operational and diagnostic services
  • 6.2 Nov 05, 2019: OPKO Health reports 2019 third quarter business highlights and financial results
  • 6.3 Aug 30, 2019: Santen announces topline pivotal data for DE-128 (MicroShunt) demonstrating reductions in intraocular pressure and medication use in patients with mild, moderate and severe primary open-angle glaucoma

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

  • Table 1: Glaucoma Drainage Devices - Pipeline Products by Stage of Development
  • Table 2: Glaucoma Drainage Devices - Pipeline Products by Territory
  • Table 3: Glaucoma Drainage Devices - Pipeline Products by Regulatory Path
  • Table 4: Glaucoma D

List of Figures

  • Figure 1: Glaucoma Drainage Devices - Pipeline Products by Stage of Development
  • Figure 2: Glaucoma Drainage Devices - Pipeline Products by Territory
  • Figure 3: Glaucoma Drainage Devices - Pipeline Products by Regulatory Path
  • Figure 4: Glaucoma Drainage Devices - Pipeline Products by Estimated Approval Date
  • Figure 5: Glaucoma Drainage Devices - Ongoing Clinical Trials